• 09 Mar 2018 2:09 PM | Gregory Metz

    Dear AAE members,

    I am pleased to announce that I will be conducting a free online asthma education/self-management program this summer.   I presented the original findings on this effective program at the 2016 conference in Jacksonville, Florida.  In the program, adults with asthma or caregivers that have children with asthma are asked to share their experiences about asthma and then I make brief you tube videos sharing the NHLBI guidelines regarding topics such as triggers, medications, and asthma control.   Program participants found that the interactive engaging communication really helped them to better understand asthma and how to self-manage it.   

    If you are interested in getting involved in this program there are two potential realms:

    1) If you work with adults or caregivers that have children with asthma they can enroll (you can share the flyer with them)

    2) If you would like to participate as part of the team to conduct the program let me know

    Please contact me for additional information and/or you would like me to email you the flyer for this program.


    Stuart Tousman, Ph.D.   


  • 21 Feb 2018 1:22 PM | Anonymous

    As an important partner, Teva Respiratory wanted to make you aware of the upcoming launch of QVAR® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol, which will be available by prescription beginning on February 12, 2018. Teva will be discontinuing QVAR® (beclomethasone dipropionate HFA). Patients and caregivers are encouraged to speak with their doctors to learn more about how this discontinuation may affect their current treatment plans. 

    Important limitation of use, QVAR® RediHaler™ is not indicated for the relief of acute bronchospasm. QVAR ® RediHaler ™ (beclomethasone dipropionate HFA) Inhalation Aerosol is indicated for the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age or older. It contains the same small-particle medication as the currently-available QVAR®, but in a "spacer-free" design (do not use with a spacer). The inhaler no longer requires priming and in addition, it utilizes innovative “breath-actuated” inhaler technology to deliver the medicine, eliminating the need for hand-breath coordination. Prescribing information and additional details:

  • 23 Jan 2018 10:14 AM | Anonymous

    The Association of Asthma Educators invites submission of abstracts/project posters related to any aspect of diagnosis, care or education of asthma. The submissions will be peer reviewed by a conference committee panel, and selected authors of accepted abstracts/project posters will be invited to present a poster presentation at the Association of Asthma Educators’ annual conference in Phoenix, AZ at the Arizona Grand Resort from July 20-22, 2018. Three “top” submissions will be chosen for oral presentations during the conference agenda. You do not have to be a member of AAE to submit an abstract/poster. However, if accepted, the presenter must be registered for the AAE meeting and a current AAE member in good standing of their membership dues to present at conference. The top abstract/poster winner after review will be provided free registration for the 2019 conference!

    Please download for complete details:

    2018 CALL FOR Asthma Project Poster for 2017 AAE Conference.pdf

    Abtract Poster Submission Specification.pdf

  • 20 Dec 2017 8:43 PM | Gregory Metz

    Please help us congratulate Lorene Alba, AE-C, on being nominated for an AAE Asthma Advocate Award.  

    Read more at 

  • 08 Nov 2017 5:26 PM | Anonymous

    As we are entering the influenza season, it is strongly recommended that those with asthma receive a flu vaccine.
    Learn more at:

  • 13 Oct 2017 1:55 PM | Gregory Metz

    We are in the process of updating our organization's policies and procedures.    The last review was several years ago.   I have attached  proposed edits to AAE’s policies for your review and comment.

    The underlined parts are the proposed changes.

    Please send any comments to: by Nov. 13th


    Gregory Metz

    AAE President   

    On the "Mailing List Policy", the following would be added

    Requests for mailings, electronic communications, announcements, questionnaires or research by AAE members to involve AAE membership will need to be reviewed and approved by the executive board for appropriateness

  • 11 Oct 2017 3:18 PM | Anonymous

    Today is CHIP awareness day when the AAP has urged everyone to communicate with the congressional delegations the importance of maintaining the funding for CHIP (Children's Health Insurance Program) which has already been allowed to expire.  It is a bedrock program to support children with chronic health conditions to get the complex care they need.  It supports families that are slightly better off than those who qualify for Medicaid with much lower out-of-pocket expenses.  A recent study found that Children with asthma in families with $20-30,000 annual income would face annual out-of-pocket expenses on marketplace Medicaid of $284 vs. only $27 with CHIP coverage.  We know asthma care is expensive and reduces parental attendance at work, so ANY increase in out-of-pocket costs will have a double impact by decreasing compliance and worsen asthma outcomes.  Today is CHIP day for the AAP, but folks who can't get to it today still need to communicate with their legislators asap.  It is a crucial imperiled program for kids. 

    Today is CHIP day for the AAP,  if you can't get to it today, please communicate with your legislators asap about the importance of this program.  It is a crucial imperiled program for kids.

    Find your representatives:

  • 06 Oct 2017 1:57 PM | Gregory Metz

    We are in the process of updating our organization's policies and procedures.    The last review was several years ago.   I have attached  proposed edits to AAE’s policies for your review and comment.

    The underlined parts are the proposed changes.

    Please send any comments to: by September 25.


    Gregory Metz

    AAE President  

    In the awards policy section of the “policies and procedures” it states:

    A call for nominations will be posted on the Association website and will be made by e-blast to all members.  (we propose removing “and may be made by mail if necessary”

  • 14 Sep 2017 1:07 PM | Gregory Metz

    Check out our new webinars and podcasts added to the Education Tab on the website.


  • 01 Sep 2017 9:07 AM | Administrators AAE (Administrator)

    Since 2012, more than 73,000 schools have enrolled in the EpiPen4Schools® program, and results from surveys of participating schools demonstrate the need to continue to engage all schools. According to the most recently published data from our EpiPen4Schools survey, there were more than 2,000 anaphylactic events in 2014/2015, as reported by more than 12,000 schools participating in the program, and of the events where epinephrine was administered, half were treated with an epinephrine auto-injector provided by the program. Food was the most common trigger, though in 33% of events, the trigger was unknown.  Nearly 25% of these occurred in individuals with no previously known allergies.

    For students and other individuals with known severe allergies, they must always take care to avoid their allergens and have access to epinephrine, the only first-line treatment for anaphylaxis, should exposure occur. There are several epinephrine choices now available on the market. If your constituents have a prescription for EpiPen® or EpiPen Jr® Auto-Injectors, please help ensure they are familiar with the patient resources Mylan offers.

    Mylan’s Epinephrine Auto-Injector Patient Resources

    ·         Includes information about the authorized generic for EpiPen Auto-Injector; the savings cards available for both EpiPen Auto-Injector and the authorized generic; Mylan’s patient assistance program and the EpiPen4Schools program.

     EpiPen4Schools Infographic and EpiPen4Schools Fact Sheet

    ·         Provides more detail about the EpiPen4Schools program, including participation statistics, survey results and myths and facts.

    Additional information 

70 Buckwalter Rd. Ste 900, #330, Royersford, PA 19468   |   Phone: 888-988-7747   |   Email:

Privacy Policy

Powered by Wild Apricot Membership Software